PACE: A phase III trial of CAPOX versus anti-PD-1 inhibitor as adjuvant therapy for patients with dMMR/MSI-H stage III colon cancer

被引：0
|
作者：
Hou, Zhenlin
Jiang, Wu
Tang, Jinghua
Xiao, Binyi
Li, Yuan
Li, Dandan
Zhang, Xiaoshi
Pan, Zhi-Zhong
Ding, Peirong
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Biotherapy Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3637
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anti-PD-1 compounds targeting MSI-H/dMMR tumors
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (SUPPL 5) : 102 - 106
  • [2] Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy
    Chida, Keigo
    Kawazoe, Akihito
    Suzuki, Toshihiro
    Kawazu, Masahito
    Ueno, Toshihide
    Takenouchi, Kazumasa
    Nakamura, Yoshiaki
    Kuboki, Yasutoshi
    Kotani, Daisuke
    Kojima, Takashi
    Bando, Hideaki
    Mishima, Saori
    Kuwata, Takeshi
    Sakamoto, Naoya
    Watanabe, Jun
    Mano, Hiroyuki
    Ikeda, Masafumi
    Shitara, Kohei
    Endo, Itaru
    Nakatsura, Tetsuya
    Yoshino, Takayuki
    CLINICAL CANCER RESEARCH, 2022, 28 (10) : 2110 - 2117
  • [3] Oncologic Outcomes after Adjuvant Chemotherapy Using FOLFOX in MSI-H Sporadic Stage III Colon Cancer
    Seung Yeop Oh
    Do Yoon Kim
    Young Bae Kim
    Kwang Wook Suh
    World Journal of Surgery, 2013, 37 : 2497 - 2503
  • [4] Oncologic Outcomes after Adjuvant Chemotherapy Using FOLFOX in MSI-H Sporadic Stage III Colon Cancer
    Oh, Seung Yeop
    Kim, Do Yoon
    Kim, Young Bae
    Suh, Kwang Wook
    WORLD JOURNAL OF SURGERY, 2013, 37 (10) : 2497 - 2503
  • [5] Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer
    Loree, Jonathan M.
    Sha, Aaron
    Soleimani, Maryam
    Kennecke, Hagen F.
    Ho, Maria Y.
    Cheung, Winson Y.
    Mulder, Karen E.
    Abadi, Shirin
    Spratlin, Jennifer L.
    Gill, Sharlene
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : 156 - 163
  • [6] Survival impact of CAPOX versus FOLFOX in the adjuvant treatment of stage III colon cancer.
    Loree, Jonathan M.
    Sha, Aaron
    Soleimani, Maryam
    Ho, Maria Yi
    Kennecke, Hagen F.
    Cheung, Winson Y.
    Mulder, Karen E.
    Abadi, Shirin
    Spratlin, Jennifer L.
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Delayed and persistent multisystem toxicities of adjuvant anti-PD-1 therapy for stage III melanoma
    Goodman, Rachel S.
    Justice, Joy
    Gardner, Laura J.
    Singh, Reena
    Dewan, Anna K.
    Johnson, Douglas B.
    EUROPEAN JOURNAL OF CANCER, 2023, 192
  • [8] Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy
    Jacques, S. K.
    McKeown, J.
    Grover, P.
    Park, B.
    Zaremba, A.
    Dimitriou, F.
    Rashid, M. F. Harunal
    Namikawa, K.
    Mooradian, M.
    Placzke, J.
    Allayous, C.
    Mehmi, I.
    DePalo, D.
    Wicky, A.
    Schwarze, J. K.
    Nakamura, Y.
    Benannoune, N.
    Menzies, A. M.
    Lo, S. N.
    Carlino, M. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S915 - S916
  • [9] Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients
    Di Pietro, Francesca Romana
    Verkhovskaia, Sofia
    Falcone, Rosa
    Poti, Giulia
    Carbone, Maria Luigia
    Morelli, Maria Francesca
    Zappala, Albina Rita
    Morese, Roberto
    Di Rocco, Zorika Christiana
    Piesco, Gabriele
    Chesi, Paolo
    Failla, Cristina Maria
    Marchetti, Paolo
    De Galitiis, Federica
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial
    Sobrero, Alberto
    Lonardi, Sara
    Rosati, Gerardo
    Di Bartolomeo, Maria
    Ronzoni, Monica
    Pella, Nicoletta
    Scartozzi, Mario
    Banzi, Maria
    Zampino, Maria Giulia
    Pasini, Felice
    Marchetti, Paolo
    Cantore, Maurizio
    Zaniboni, Alberto
    Rimassa, Lorenza
    Ciuffreda, Libero
    Ferrari, Daris
    Zagonel, Vittorina
    Maiello, Evaristo
    Barni, Sandro
    Rulli, Eliana
    Labianca, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15) : 1478 - +
12345